DocCheck Guano AG
DocCheck Guano AG is a Cologne-based, wholly-owned subsidiary of DocCheck AG that operates as a healthcare seed-stage investor and startup hatchery, providing equity capital, healthcare expertise, market access, and the M.E.S.H. Camp program to early-stage healthcare startups.
- Company typePrivate
- Founded2013
- HeadquartersCologne, Germany
- Headcount51–100
- GTM typeB2B
- OfferingServices
What DocCheck Guano AG does
DocCheck Guano AG is a healthcare-focused seed-stage investor and startup hatchery established in 2013 and headquartered in Cologne, Germany. The company is structured as a private Aktiengesellschaft (stock corporation) and operates as a wholly-owned subsidiary of DocCheck AG, a publicly listed German healthcare community and communications group. Guano AG's mission is to provide early-stage healthcare startups with a packaged combination of seed capital, healthcare-specific know-how, corporate management expertise, and direct access to the DocCheck community of medical professionals. Its stated positioning, in contrast to typical financial investors, emphasizes sustainable long-term value creation and operational partnership rather than rapid-return venture finance.
The company's product surface consists of two interlocking offerings: (1) seed equity financing rounds for early-stage healthcare startups, with disclosed minority stakes taken in portfolio companies such as HRTBT Medical Solutions GmbH (web-based quality management software), PatientZero Games GmbH (serious medical training games), Curassist GmbH (nursing self-employment platform), BetterDoc GmbH (specialist matching), Fysio24 B.V. (physiotherapy app), Amparo GmbH, and Mammoth Hunters S.L.; and (2) the M.E.S.H. (Medical Entrepreneur Start-up Hospital) Camp, an annual 1.5-day workshop, mentoring, and pitch event held in Berlin that serves both as a deal-sourcing channel and as a community-building mechanism. Investment activities have included co-investments with High-Tech Gründerfonds and structured support partnerships with DocCheck Research for startup concept validation.
DocCheck Guano AG generates revenue through equity participation in its portfolio companies, with returns tied to long-dated exit proceeds and equity appreciation rather than recurring service fees, licensing, or product sales. There is no evidence of third-party fund management, management fees, or carried interest being charged externally; Guano appears to operate as a captive investment vehicle within the broader DocCheck corporate group. The parent DocCheck AG reported EUR 53.7 million in consolidated revenue in 2024, but standalone financials for Guano AG are not separately disclosed. Operational scale signals include a headcount band of 51-100 (attributable to the broader group context) and approximately seven identified portfolio companies concentrated in the German healthcare startup ecosystem with select international exposures.
DocCheck Guano AG firmographics
Firmographics- Name
- DocCheck Guano AG
- Legal name
- DocCheck Guano AG
- Website
- https://guano.ag
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- DocCheck Guano AG is a Cologne-based, wholly-owned subsidiary of DocCheck AG that operates as a healthcare seed-stage investor and startup hatchery, providing equity capital, healthcare expertise, market access, and the M.E.S.H. Camp program to early-stage healthcare startups.
- Ownership category
- akta.pro rank
DocCheck Guano AG industry classification
Industry- Product category
- Healthcare Venture Capital / Startup Incubation
- akta.pro primary industry
- Corporate Fintech / Insurtech CVC (Financial-services-led CVC) (FSANAHAK)
- akta.pro secondary industries
- Health & Medical Research Grantmaking Foundations (BPAGAKAL), Entrepreneurship, Business & Innovation Camps (EDAMALAL)
Keywords
Where DocCheck Guano AG is headquartered
LocationHeadquarters
- HQ city
- Cologne
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
DocCheck Guano AG business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Seed Investment Returns: DocCheck Guano AG generates returns through equity participation in healthcare startups. They acquire stakes in early-stage companies in exchange for capital and support services. Their revenue model is based on equity appreciation and potential exit proceeds from portfolio companies, rather than direct product or service sales.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
DocCheck Guano AG product offering
Product offeringCore offering
DocCheck Guano AG operates as a healthcare startup hatchery and seed investor. It provides seed-stage financing, corporate management and healthcare expertise, market access through the DocCheck community of medical professionals, and a network of founders and investors. The company also organizes the M.E.S.H. (Medical Entrepreneur Start-up Hospital) Camp, a 1.5-day field hospital camp event featuring workshops, mentoring, and pitch competitions for healthcare entrepreneurs.
Product overview
DocCheck Guano AG is a healthcare startup incubator and seed investor, not a traditional SaaS or technology product company. The company operates two interconnected offerings: (1) a Seed Financing and Startup Incubation service that provides capital, healthcare and business expertise, market access, and networking to early-stage healthcare startups, and (2) the M.E.S.H. Camp program, an annual startup camp event featuring workshops, mentoring, and pitch competitions for healthcare entrepreneurs. The company is a wholly-owned subsidiary of DocCheck AG.
Differentiator
Problem solved
Functional benefit
Products and services
- Seed Financing and Startup Incubation
- M.E.S.H. Camp
Quantifiable outcome
- M.E.S.H Camp has facilitated connections across 10+ countries and multiple portfolio companies have achieved market validation and recognition.
Companies that use DocCheck Guano AG
Customer profileNamed customers5 records
Segments1 record
Ideal customer profiles1 record
DocCheck Guano AG technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
DocCheck Guano AG partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DocCheck ResearchminorCollaboration with DocCheck Research for market research services, including the 1-2-3 Start-up Check program that helps validate healthcare startup concepts.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
DocCheck Guano AG competitors and assessment
Company assessmentBroad incumbents
- Novartis Venture Fund: Global corporate venture fund of Novartis investing in life sciences and digital health ventures. Operates at a much larger scale and later stages than Guano but shares the healthtech focus.
- Leaps by Bayer: Corporate venture arm of Bayer AG investing in health and agriculture breakthroughs with significantly larger check sizes. Operates in the same healthcare CVC category as Guano but at global scale and across later stages.
- Sanofi Ventures: Corporate venture arm of Sanofi focused on early-stage digital health and biotech investments. Similar health-only focus but with a global mandate and larger fund size.
- Roche Venture Fund: Corporate venture fund of Roche providing early- and growth-stage financing in diagnostics, digital health, and biotech. Large incumbent comparator in the healthcare CVC space.
- Boehringer Ingelheim Venture Fund: Germany-based pharma corporate venture fund backing early- and mid-stage biotech and healthtech startups. Closest large-pharma CVC analog to Guano with similar early-stage European health focus.
Direct peers
- XLHEALTH: Berlin-based investor and accelerator dedicated exclusively to digital health startups in Europe. Directly comparable in mission, geography, and stage focus to Guano AG.
- Asabys Partners: European venture capital firm investing in healthtech and biotech across early stages. Direct peer in size, stage, and health-only focus, though based in Barcelona rather than Cologne.
- Digital Health Ventures: Berlin-based early-stage VC focused on digital health startups in the DACH region. Closest direct competitor targeting the same seed-stage healthtech founder pool.
- High-Tech Gründerfonds: Germany's leading seed-stage tech VC and explicit co-investor with Guano in HRTBT Medical Solutions. Provides seed financing in tech/health verticals using a comparable model.
- Startupbootcamp Digital Health Berlin: European healthtech accelerator program operating in Berlin alongside Guano. Competes for the same founder pool via a structured accelerator/mentorship model with corporate partners.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
DocCheck Guano AG social profiles
Digital presenceDocCheck Guano AG financial estimates
Financial estimateRevenue estimate
Valuation estimate
DocCheck Guano AG leadership team
Management profileNumber of profiles
Profiles5 records
DocCheck Guano AG funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DocCheck Guano AG M&A and investment
M&A and investmentM&A
Investments8 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DocCheck Guano AG
What does DocCheck Guano AG do?
DocCheck Guano AG operates as a healthcare startup hatchery and seed investor. It provides seed-stage financing, corporate management and healthcare expertise, market access through the DocCheck community of medical professionals, and a network of founders and investors. The company also organizes the M.E.S.H. (Medical Entrepreneur Start-up Hospital) Camp, a 1.5-day field hospital camp event featuring workshops, mentoring, and pitch competitions for healthcare entrepreneurs.
Is DocCheck Guano AG a public or private company?
DocCheck Guano AG is a private company. It is classified as corporate owned and is currently operating.
When was DocCheck Guano AG founded?
DocCheck Guano AG was founded in 2013. It employs 51 to 100 people.
Where is DocCheck Guano AG based?
DocCheck Guano AG is headquartered in Cologne, Germany, in the Europe region.
How does DocCheck Guano AG make money?
One revenue line is on record: seed Investment Returns.
Who are DocCheck Guano AG's main competitors?
Broad incumbents on record are Novartis Venture Fund, Leaps by Bayer, Sanofi Ventures, Roche Venture Fund and Boehringer Ingelheim Venture Fund. Direct peers are XLHEALTH, Asabys Partners, Digital Health Ventures, High-Tech Gründerfonds and Startupbootcamp Digital Health Berlin.
Does DocCheck Guano AG have an API?
No public API is recorded for DocCheck Guano AG.
What industry is DocCheck Guano AG in?
DocCheck Guano AG's product category is Healthcare Venture Capital / Startup Incubation. Its primary akta.pro industry code is FSANAHAK, Corporate Fintech / Insurtech CVC (Financial-services-led CVC), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations.